Mitochondrial dysfunction in chronic lung disease Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease Year: 2016
Matrix dysfunction and the aging lung Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration Year: 2018
Mitochondrial dysfunction in lung ageing and disease Source: Eur Respir Rev, 29 (157) 200165; 10.1183/16000617.0165-2020 Year: 2020
Proteasome function in lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013
Proteasome function in pulmonary fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-induced acute pneumonitis in mice Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014
Role of poly(ADP-ribose) polymerase-1 and its inhibitor in ventilator-induced lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004
Estradiol exacerbates superoxide-induced nitrative lung injury and pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008
Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity Source: Eur Respir J 2007; 30: Suppl. 51, 393s Year: 2007
Lung fibrosis - a disease of mitochondrial dysfunction Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease Year: 2018
Oxidative stress and lung permeability during chlorine-induced acute lung injury in mice Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013
LATE-BREAKING ABSTRACT: Age-related PINK1 deficiency promotes mitochondria dysfuntion, epithelial injury and fibrosis in the lung Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Regulation of autophagy in amiodarone induced pulmonary fibrosis Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013
The effect of dasatinib, a novel tyrosine kinase inhibitor, on the regression of pulmonary fibrosis in mice Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015
Inhibition of p38 MAPK improves heart function in experimental pressure-overload induced right ventricular hypertrophy and failure Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014
Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005